GO:0017172 cysteine dioxygenase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0017172 cysteine dioxygenase activity describes the catalysis of L-cysteine and oxygen to 3-sulfino-L-alanine and a proton, a key step in cysteine catabolism.
• The enzyme CDO1 (cysteine dioxygenase type 1) is the primary mammalian protein carrying this activity and is central to cysteine homeostasis and taurine biosynthesis.
• CDO1 is regulated by hypoxia-inducible factor and contributes to cysteine homeostasis under low oxygen in model organisms.
• Altered cysteine dioxygenase activity is linked to metabolic dysfunction, cancer, and developmental processes, making it a target for disease research.
• Assays for cysteine dioxygenase activity allow simultaneous quantitation of substrate and product, facilitating high-throughput screening.
• CRISPR-based models (knockout, knock-in, overexpression) are essential to dissect the causal roles of CDO1 and related genes in physiology and disease.
Description
Cysteine dioxygenase activity (GO:0017172) is a molecular function that catalyzes the oxidation of L-cysteine to 3-sulfino-L-alanine, a critical step in cysteine catabolism and taurine biosynthesis. This activity is essential for maintaining cysteine homeostasis, as excessive cysteine can be neurotoxic and contribute to oxidative stress. The enzyme responsible, CDO1, is highly conserved and its dysregulation has been implicated in various pathophysiological conditions, including cancer and metabolic disorders. Understanding the mechanism, regulation, and disease relevance of cysteine dioxygenase activity is therefore of broad interest to researchers in biochemistry, cell biology, and medicine. This article provides a comprehensive overview of GO:0017172, integrating authoritative QuickGO data with verified PubMed literature to support research and drug discovery efforts.
cysteine dioxygenase activity At A Glance
| GO ID | GO:0017172 |
|---|---|
| GO term | cysteine dioxygenase activity |
| Ontology | molecular_function |
| Synonym | (none) |
| Major function | Catalysis of L-cysteine oxidation to 3-sulfino-L-alanine |
| Reaction | L-cysteine + O2 = 3-sulfino-L-alanine + H+ |
| Cofactor | Non-heme Fe(II) (inferred from enzyme mechanism) |
| Subcellular location | Cytoplasm (inferred from typical localization of CDO1) |
| Related genes | CDO1 (cysteine dioxygenase type 1) |
What Is GO:0017172?
According to the Gene Ontology, cysteine dioxygenase activity (GO:0017172) is defined as the catalysis of the reaction: L-cysteine + O2 = 3-sulfino-L-alanine + H+. This reaction represents the first and rate-limiting step in the cysteine sulfinic acid pathway, directing cysteine toward taurine production or further oxidation to sulfate.
Why Is cysteine dioxygenase activity Important in Cell Biology?
Cysteine dioxygenase activity is a pivotal node in sulfur amino acid metabolism, controlling the flux of cysteine toward taurine, sulfate, and pyruvate. Dysregulation of this activity leads to altered cysteine levels, which are associated with metabolic diseases, neurodegeneration, and cancer. Moreover, the enzyme's sensitivity to oxygen availability links it to hypoxia responses and cellular stress adaptation. Thus, understanding cysteine dioxygenase activity is crucial for developing therapeutic strategies targeting cysteine metabolism.
• Maintains cysteine homeostasis and prevents cysteine toxicity.
• Produces taurine, which is essential for bile acid conjugation, osmoregulation, and antioxidant defense.
• Links to energy metabolism via the CDO1-Camkk2-AMPK axis, affecting NAFLD progression.
• Modulated by hypoxia-inducible factor, impacting cysteine homeostasis under low oxygen.
• Altered expression and activity observed in various cancers, suggesting a role in tumorigenesis.
• Provides a target for metabolic engineering and drug discovery.
• Its activity can be measured with simplified assays, enabling high-throughput screening.
• Conserved across species, from fungi to mammals, facilitating comparative studies.
• Involved in developmental processes and stress responses in pathogens like Histoplasma capsulatum.
• Potential biomarker for diseases related to sulfur metabolism.
Molecular Mechanism of cysteine dioxygenase activity
Substrate binding and iron coordination
In simple terms: The enzyme grabs cysteine and holds it next to an iron atom.
Cysteine dioxygenase (CDO1) contains a non-heme Fe(II) center coordinated by three histidine residues. The substrate L-cysteine binds to the iron in a bidentate fashion via its amino and thiolate groups, positioning it for oxidation.
Catalytic oxidation
In simple terms: Oxygen is added to cysteine, turning it into a new molecule.
Molecular oxygen binds to the iron center and is activated, leading to the insertion of one oxygen atom into the cysteine thiol, forming the sulfinic acid product 3-sulfino-L-alanine. The reaction releases a proton.
Product release and enzyme turnover
In simple terms: The product leaves, and the enzyme is ready for another round.
After formation, 3-sulfino-L-alanine is released from the active site, and the enzyme returns to its resting state. The catalytic cycle can be monitored by assays that quantify both substrate and product.
Regulation by oxygen and hypoxia
In simple terms: Low oxygen changes how much of this enzyme is made.
In Caenorhabditis elegans, hypoxia-inducible factor (HIF) induces cysteine dioxygenase expression, promoting cysteine homeostasis under hypoxic conditions. This suggests a conserved regulatory link between oxygen sensing and cysteine metabolism.
Post-translational and transcriptional control
In simple terms: Cells can adjust enzyme levels and activity in multiple ways.
CDO1 expression is regulated at the transcriptional level by various factors, and its activity can be influenced by cysteine availability and oxidative stress. The CDO1-Camkk2-AMPK axis exemplifies how cysteine dioxygenase activity integrates with cellular energy sensing.
Key Genes Involved in GO:0017172 cysteine dioxygenase activity
The following genes and proteins are directly or indirectly involved in cysteine dioxygenase activity and its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CDO1 | Catalyzes cysteine oxidation to 3-sulfino-L-alanine | Central enzyme; target for metabolic and cancer studies |
| CAMKK2 | Kinase activated by CDO1-derived signals | Mediates AMPK activation in exercise-induced NAFLD protection |
| AMPK | Energy sensor | Downstream effector of CDO1-Camkk2 axis |
| HIF-1 | Hypoxia-inducible transcription factor | Induces CDO1 expression under hypoxia |
| CSAD | Decarboxylates 3-sulfino-L-alanine to taurine | Next step in taurine biosynthesis |
| GOT1 | Transaminates 3-sulfino-L-alanine to sulfate | Alternative pathway for cysteine catabolism |
| GCLC | Glutamate-cysteine ligase catalytic subunit | Competes for cysteine in glutathione synthesis |
| GCLM | Glutamate-cysteine ligase modifier subunit | Regulates glutathione synthesis |
| SLC7A11 | Cystine/glutamate antiporter | Influences cysteine availability |
| CTH | Cystathionine gamma-lyase | Transsulfuration pathway, cysteine production |
| CBS | Cystathionine beta-synthase | Transsulfuration pathway |
| MST | 3-mercaptopyruvate sulfurtransferase | Cysteine catabolism to sulfide |
| TST | Thiosulfate sulfurtransferase | Mitochondrial sulfur metabolism |
| SUOX | Sulfite oxidase | Oxidizes sulfite to sulfate |
| CDO1 (fungal) | Cysteine dioxygenase in Histoplasma capsulatum | Dimorphic switch and stress response |
| CDO1 (C. elegans) | Cysteine dioxygenase ortholog | Hypoxia response and cysteine homeostasis |
| Taurine transporter (TauT) | Uptake of taurine | Taurine utilization in leukemia |
How Is cysteine dioxygenase activity Regulated?
Cysteine dioxygenase activity is regulated at multiple levels. Transcriptionally, CDO1 is induced by hypoxia-inducible factor (HIF) under low oxygen conditions, as shown in C. elegans. In mammals, CDO1 expression is influenced by nutritional status and hormones, and its activity can be modulated by cysteine availability and oxidative stress. Additionally, the CDO1-Camkk2-AMPK axis links cysteine dioxygenase activity to energy sensing and exercise-induced metabolic benefits in NAFLD. Post-translational modifications and iron availability may also affect enzyme activity, though these mechanisms require further study.
cysteine dioxygenase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CDO1 | Cancer (various solid tumors) | CDO1 knockout cancer cell lines; xenograft models |
| CDO1 | NAFLD | Liver-specific Cdo1 knockout mice; exercise intervention |
| CDO1 | Leukemia | Taurine supplementation in leukemia models; CDO1 overexpression |
| CDO1 | Neurodegeneration | Neuron-specific CDO1 knockout mice |
| CDO1 (fungal) | Histoplasmosis | Histoplasma capsulatum cdo1 deletion strains |
Cysteine dioxygenase activity in cancer
Altered CDO1 expression and cysteine dioxygenase activity have been observed in various cancers. CDO1 is often downregulated in tumors, leading to increased cysteine levels that support antioxidant defense and tumor growth. In leukemia, taurine produced via the cysteine dioxygenase pathway drives glycolysis and promotes leukemogenesis, highlighting a metabolic vulnerability.
Metabolic disorders and NAFLD
The CDO1-Camkk2-AMPK axis mediates the protective effects of exercise against non-alcoholic fatty liver disease (NAFLD) in mice. Activation of this axis enhances fatty acid oxidation and reduces lipogenesis, suggesting that cysteine dioxygenase activity is beneficial in metabolic syndrome.
Neurodegeneration and cysteine toxicity
Deficiency in cysteine dioxygenase activity leads to elevated cysteine, which can cause neurotoxicity and is implicated in neurodegenerative conditions. Proper cysteine catabolism is essential for neuronal health.
Infectious disease and fungal pathogenesis
In the dimorphic fungus Histoplasma capsulatum, cysteine dioxygenase activity is present in both mold and yeast morphotypes and exhibits strain variation, suggesting a role in adaptation and virulence.
From cysteine dioxygenase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of CDO1 loss on cysteine levels? | CDO1 knockout cell lines (e.g., HepG2, HEK293) |
| How does a point mutation in the iron-binding site affect activity? | CDO1 point-mutant knock-in cells (e.g., H140A) |
| Does overexpression of CDO1 protect against NAFLD? | Liver-specific CDO1 overexpression mice |
| How does CDO1 tagging affect localization? | CDO1-GFP knock-in cells |
| What is the role of CDO1 in leukemia? | CDO1 knockout or overexpression in leukemia cell lines |
| Can cysteine dioxygenase activity be modulated by small molecules? | High-throughput screening with purified enzyme |
How to Study the cysteine dioxygenase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| HPLC assay | Substrate and product concentrations | Enzyme kinetics and inhibitor screening |
| qRT-PCR | CDO1 mRNA levels | Gene expression under different conditions |
| Western blot | CDO1 protein levels | Validation of expression changes |
| LC-MS metabolomics | Cysteine, taurine, and related metabolites | Pathway flux analysis |
| CRISPR knockout screen | Gene essentiality and pathway interactions | Discovery of novel regulators |
| Immunofluorescence | Subcellular localization of CDO1 | Protein trafficking studies |
| Enzyme-linked assay | Cysteine dioxygenase activity in lysates | High-throughput screening |
| RNA-seq | Transcriptome-wide changes | Identifying CDO1-regulated pathways |
Enzymatic activity assays
Cysteine dioxygenase activity can be measured using a simplified assay that simultaneously quantitates both substrate (L-cysteine) and product (3-sulfino-L-alanine) via HPLC or mass spectrometry. This method is suitable for screening inhibitors or activators.
Gene expression analysis
Quantitative RT-PCR and RNA-seq can assess CDO1 mRNA levels under various conditions, such as hypoxia or exercise. Western blotting detects protein levels.
Metabolomics
LC-MS-based metabolomics quantifies cysteine, taurine, and related metabolites to infer flux through the cysteine dioxygenase pathway. This is useful in disease models and clinical samples.
CRISPR screening
Genome-wide CRISPR knockout screens can identify genes that modulate cysteine dioxygenase activity or sensitivity to cysteine deprivation. Such screens help uncover synthetic lethal interactions.
How CRISPR Can Be Used to Study GO:0017172 cysteine dioxygenase activity
Knockout
CRISPR-Cas9 knockout of CDO1 in cell lines or animal models abolishes cysteine dioxygenase activity, leading to elevated cysteine and reduced taurine. These models are used to study the consequences of loss of function in cancer, metabolism, and neurobiology.
Point Mutation
Introducing point mutations in the catalytic residues of CDO1 (e.g., histidines coordinating iron) via CRISPR base editing or homology-directed repair allows precise dissection of the enzymatic mechanism and its physiological relevance.
Knock-in
Knock-in of tagged CDO1 (e.g., GFP or FLAG) enables real-time tracking of protein localization and interaction. Knock-in of disease-associated variants can model human mutations.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of CDO1 increases cysteine dioxygenase activity, which can protect against metabolic stress or alter tumor growth. These models help establish causality.
How EDITGENE Supports cysteine dioxygenase activity Research
Researchers studying cysteine dioxygenase activity-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as altered cysteine levels or disease progression. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell and animal models, enabling rigorous functional studies.
Contact EDITGENE today to design your custom CRISPR model for cysteine dioxygenase activity research.
Frequently Asked Questions About cysteine dioxygenase activity
What is cysteine dioxygenase activity?
Cysteine dioxygenase activity (GO:0017172) is the catalysis of L-cysteine and oxygen to 3-sulfino-L-alanine and a proton, a key step in cysteine catabolism.
What genes are involved in cysteine dioxygenase activity?
The primary gene is CDO1, which encodes the enzyme cysteine dioxygenase type 1. Other related genes include CSAD, GOT1, and SLC7A11.
What is the function of CDO1?
CDO1 catalyzes the oxidation of cysteine to 3-sulfino-L-alanine, regulating cysteine homeostasis and taurine biosynthesis.
How is cysteine dioxygenase activity regulated?
It is regulated by oxygen availability via HIF, by nutritional status, and through the CDO1-Camkk2-AMPK axis.
What diseases are associated with cysteine dioxygenase activity?
Altered activity is linked to cancer, NAFLD, neurodegeneration, and fungal pathogenesis.
How can I measure cysteine dioxygenase activity?
A simplified assay allows simultaneous quantitation of substrate and product using HPLC or mass spectrometry.
What animal models are available for studying cysteine dioxygenase?
CDO1 knockout mice, liver-specific overexpression models, and C. elegans mutants are commonly used.
Is cysteine dioxygenase activity conserved across species?
Yes, from fungi to mammals, indicating its fundamental role in sulfur metabolism.
What is the role of cysteine dioxygenase in cancer?
CDO1 is often downregulated in tumors, and its product taurine can promote leukemia progression.
How can CRISPR be used to study cysteine dioxygenase activity?
CRISPR knockout, knock-in, point mutation, and overexpression models enable precise functional studies of CDO1 and related genes.
Conclusion
Cysteine dioxygenase activity (GO:0017172) is a fundamental molecular function that governs cysteine catabolism and taurine biosynthesis. Its dysregulation is implicated in a wide range of diseases, from cancer to metabolic disorders. By leveraging CRISPR-based models and advanced analytical methods, researchers can uncover the precise roles of CDO1 and its regulators, paving the way for novel therapeutic interventions. EDITGENE stands ready to support these efforts with tailored gene editing services.
References
- 1. Sharma S et al.. 2025. Taurine from tumour niche drives glycolysis to promote leukaemogenesis.. Nature 644(8075):263-272 PMID: 40369079
- 2. Chen M et al.. 2023. Cdo1-Camkk2-AMPK axis confers the protective effects of exercise against NAFLD in mice.. Nat Commun 14(1):8391 PMID: 38110408
- 4. Joseph CA et al.. 2007. Cysteine dioxygenase: structure and mechanism.. Chem Commun (Camb) PMID: 18019494
- 5. Siakkou E et al.. 2010. Simplified cysteine dioxygenase activity assay allows simultaneous quantitation of both substrate and product.. Anal Biochem 405(1):127-31 PMID: 20541514
- 6. Warnhoff K et al.. 2024. Hypoxia-inducible factor induces cysteine dioxygenase and promotes cysteine homeostasis in Caenorhabditis elegans.. Elife 12 PMID: 38349720
- 7. Adams MA et al.. 2020. Cysteine Dioxygenase Enzyme Activity and Gene Expression in the Dimorphic Pathogenic Fungus Histoplasma capsulatum Is in both the Mold and Yeast Morphotypes and Exhibits Substantial Strain Variation.. J Fungi (Basel) 6(1) PMID: 32069814
- 8. Chen M et al.. 2023. Cysteine dioxygenase type 1 (CDO1): Its functional role in physiological and pathophysiological processes.. Genes Dis 10(3):877-890 PMID: 37396540
